Molecular transmission networks and pre-treatment drug resistance among individuals with acute HIV-1 infection in Baoding, China

PLoS One. 2021 Dec 2;16(12):e0260670. doi: 10.1371/journal.pone.0260670. eCollection 2021.

Abstract

Background: Human immunodeficiency virus type 1 (HIV-1) genetic diversity and pre-treatment drug resistance (PDR) are major barriers to successful antiretroviral therapy (ART). In China, sexual intercourse is the most frequent route of HIV-1 transmission. However, few studies have analyzed PDR and transmission networks in detail among individuals in China with acute HIV-1 infection and their sexual contacts.

Methods: A cross-sectional study was conducted in Baoding City, Hebei Province, China from 2019-2020. CD4 T cell counts and viral loads were assessed and a HIV-1 genotypic PDR assay was developed in-house. Transmission networks were visualized using Cytoscape with a threshold genetic distance of 0.015 among HIV-1 subtypes.

Results: From 139 newly diagnosed and drug-naïve individuals with HIV-1, 132 pol gene sequences were obtained and revealed eight HIV-1 subtypes. Circulating recombinant form (CRF)01_AE was the most frequent subtype (53.0%, 70/132) followed by CRF07_BC (26.5%, 35/132), B (13.6%, 18/132), unique recombinant forms (2.3%, 3/132), CRF55_01B (1.5%, 2/132), CRF103_01B (1.5%, 2/132), CRF65_cpx (0.8%, 1/132), and C (0.8%, 1/132). A total of 47 pol gene sequences were used to generate 10 molecular transmission networks. The overall prevalence of PDR was 7.6% and that of PDR to non-nucleotide reverse transcriptase inhibitors was 6.1%. Of three transmission networks for PDR, two were closely associated with Beijing and Tianjin, while another was restricted to sequences determined in this study.

Conclusions: These results demonstrate that during acute HIV-1 infection, PDR is transmitted in dynamic networks. This suggests that early detection, diagnosis, surveillance, and treatment are critical to effectively control HIV-1 spread.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • China
  • Cross-Sectional Studies
  • Drug Resistance, Viral / genetics*
  • Female
  • Genotype
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Infections / transmission*
  • HIV Infections / virology
  • HIV-1 / classification
  • HIV-1 / genetics
  • HIV-1 / isolation & purification
  • Humans
  • Male
  • Middle Aged
  • Phylogeny
  • RNA, Viral / chemistry
  • RNA, Viral / metabolism
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Sequence Analysis, DNA
  • Young Adult
  • pol Gene Products, Human Immunodeficiency Virus / classification
  • pol Gene Products, Human Immunodeficiency Virus / genetics

Substances

  • Anti-Retroviral Agents
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • pol Gene Products, Human Immunodeficiency Virus

Grants and funding

This study was supported by the Science and Technology Planning Project of Baoding Prefecture (1951ZF007) through the People’s Hospital of Baoding. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the funding agencies.